Stem cells have two features: the ability to differentiate along different lineages and the ability of selfrenewal. Two major types of stem cells have been described, namely, embryonic stem cells and adult stem cells. Embryonic stem cells (ESC) are obtained from the inner cell mass of the blastocyst and are associated with tumorigenesis, and the use of human ESCs involves ethical and legal considerations. The use of adult mesenchymal stem cells is less problematic with regard to these issues. Mesenchymal stem cells (MSCs) are stromal cells that have the ability to self-renew and also exhibit multilineage differentiation. MSCs can be isolated from a variety of tissues, such as umbilical cord, endometrial polyps, menses blood, bone marrow, adipose tissue, etc. This is because the ease of harvest and quantity obtained make these sources most practical for experimental and possible clinical applications. Recently, MSCs have been found in new sources, such as menstrual blood and endometrium. There are likely more sources of MSCs waiting to be discovered, and MSCs may be a good candidate for future experimental or clinical applications. One of the major challenges is to elucidate the mechanisms of differentiation, mobilization, and homing of MSCs, which are highly complex. The multipotent properties of MSCs make them an attractive choice for possible development of clinical applications. Future studies should explore the role of MSCs in differentiation, transplantation, and immune response in various diseases.
INTRODUCTON
. MSCs can be isolated from a variety of tissues, such as umbilical cord, endometrial polyps, menses blood, bone marrow, adipose tissue, etc. (23,24) ( Fig. 1 ). Stem cells have two features: the ability to differentiate along different lineages and the ability to self-renew This is because the ease of harvest and quantity obtained make these sources most practical for experimental and (74) . Two major types of stem cells have been described, namely, embryonic stem cells (ESC) and adult possible clinical applications. Recently, many MSCs have been derived from new sources, such as menstrual stem cells. ESCs are obtained from the inner cell mass of the blastocyst and are associated with tumorigenesis blood and endometrium. (6, 7, 97) . The use of human ESCs involves legal and ethical considerations (38) . These problems are less severe MSCs From Menstruation in adult stem cells. Adult stem cells have multipotency, About 400 cycles of menstruation take place in a which make them an attractive choice for clinical appliwoman's reproductive years. Usually, menstrual blood cations. This review focuses on the new origin of mesis discarded. Recently, MSCs from menstrual blood enchymal stem cells (MSCs) and signaling pathway on were discovered (42, 68, 88, 91) . This represents a new, differentiation.
noninvasive, and potent source of human MSCs for regenerative medicine. Most MSCs from menstrual blood MESENCHYMAL STEM CELLS have the ability to differentiate to muscle, especially cardiac muscle cells (42, 88) . These cells have been shown MSCs are stromal cells that possess the capacity to self-renew and also exibit multilineage differentiation to possess a remarkable myogenic capability enabling the rescue of dystrophied myocyte of Duchenne muscu-a new source of MSCs for tissue engineering applications. Meng et al. also found endometrial regenerative lar dystrophy or cardiac myocardial infarction models (42, 88) . MSCs from menstrual blood could therefore cells were able to differentiate into nine lineages: cardiomyocytic, respiratory epithelial, neurocytic, myocytic, have potential as a novel, easily accessible source of materials for myogenic stem cell-based therapy. Re-endothelial, pancreatic, hepatic, adipocystic, and osteogenic cells (66) . They also found these cells can pro-cently, Sanberg et al. showed menstrual blood-derived stem cells can be used for brain repair (76). Menstrua-duce MMP3, MMP10, GM-CSF, angiopoietin-2, and PDGF-BB (66) . In addition, they found these cells pos-tion-derived MSCs can differentiate into neurons in vitro. These cells were used to treat stroke animal model sess the ability to inhibit intracranial glioma growth (41) . Tsuji et al. found that side population cells in hu-and improvement by a mechanism that does not appear to involve cell replacement was observed. This finding man endometrium contributed to genesis of human endometrium (90) . They conclude that human endometrial raises hope that menstrual-derived stem cells are not only myogenic but also neurogenic and may have poten-side population cells may contain putative stem cells. tial for use in stroke therapy in the future.
MSCs From Endometrial Polyps MSCs From Endometrium
Endometrial polyps are localized hyperplastic overgrowths of endometrial glands and stroma around a vas-Endometrium from human uterus is a highly regenerative tissue undergoing more than 400 cycles of shed-cular core that form a sessile or pedunculated projection from the surface of the endometrium. Endometrial pol-ding, growth, and differentiation during a woman's reproductive years. Stem or progenitor cells may play a yps cause intermenstrual bleeding, irregular bleeding, and menorrhagia, and can be discovered by hysteros-major role in endometrial regeneration. Gargett and colleagues found that human endometrium contains a small copy (43) . As endometrial polyps are benign overgrowths of endometrial tissue, they may be a rich source population of MSC-like cells, which may be responsible for its cyclical growth (34, 35, 77) . They found CD146 is of MSCs. We have derived MSCs from endometrial polyps ( Fig. 2A ), which showed traditional MSC surface a good marker to identify these cells, which may provide MESENCHYMAL STEM CELLS 7 marker ( Fig. 2B ). MSCs can also differentiate into adi-fertilization, and early embryo development as well as transport to the uterus (63) . Jazedje et al. recently found pocytic, osteogenic, and neurogenic lineages ( Fig. 2C , D). They also proliferate faster than endometrial stromal MSCs derived from human fallopian tubes. These cells can differentiate into adipogenic, chondrogenic, oesto-cells and bone marrow stromal cells. Our results indicate that endometrial polyps may have potential as a novel genic, and myogenic lineages (51). They conclude human tubal MSCs can be easily isolated and expanded. source of MSCs.
Furthermore, they present a mesenchymal profile and MSCs From Fallopian Tubes are able to differentiate. The human fallopian tubes share the same embryo-MSCs From Human Cruciate Ligaments logic origin as the uterus. They have the capacity to undergo dynamic endocrine-induced changes during the Cheng et al. (14) and Ge et al. (36) found MSCs from human anterior and posterior cruciate ligaments (ACL, menstrual cycle, including cell growth and regeneration, in order to provide the unique environment required for PCL) and found these cells can differentiate into chondrocytes, adipocytes, and osteocytes. These ligaments the maintenance of male and female gamete viability, can be easily obtained from patients following total knee epidermal growth factor, basic fibroblast growth factor, TGF-β, and insulin growth factor) can regulate the pro-or cruciate ligament reconstructive surgery. They conclude that human MSCs can be isolated and expanded liferation of CFU-F (44, 62, 82 chondrocyte, muscle, neuron, islet cells, and liver cells also used the same kind of cells in a neuron-conditioned under specific in vitro conditions (55,69). Differentiamedium with the addition of sonic hedgehog (Shh) and tion is also regulated by genetic events, involving tranfibroblast growth factor 8 (FGF8), and found that these scription factors. Differentiation to a particular phenocells differentiated into dopaminergic neurons, which type pathway ( Fig. 3) can controlled by some regulatory could help recover the function of 6-OHDA-treated rats genes which can induce progenitor cells differentiation (32). We have also found that stem cells derived from to a specific lineage (18) . Besides growth factors and Wharton's jelly of the human umbilical cord can migrate induction chemicals, a microenvironment built with bioto the site of injury and differentiate to neuronal and material scaffolds can also provide MSCs with approglial cells in stroke rats (22) . Behavioral and functional priate proliferation and differentiation conditions (79, 93) . tests showed improvement in the treated group (22) . In contrast to BMSCs, WJCs have greater expansion capa-Mesoderm Differentiation bility, faster growth in vitro, and may synthesize differ-Theoretically, mesodermal differentiation is easily atent cytokines and as therapeutic cells in several preclinitainable for MSCs because they are the same embryonic cal models, such as neurodegenerative disease, cancer, origin. In osteogenic differentiation, a mixture of dexaheart disease, etc. (10, 89) . WJCs are considered an altermethasone (Dex), β-glycerophosphate (β-GP), and ascorbic native source of MSCs and deserve to be examined in acid phosphate (aP) has been widely used for induction long-term clinical trials (10) . and is demonstrated by calcium accumulation and alkaline activity (70). In adipogenesis differentiation, Dex CHARACTERIZATON OF MSCs and isobutyl-methylxanthine (IBMX) and indomethacin Surface CD marker is often used to distinguish MSC (IM) are used for induction and is shown by lipid dropfrom hematopoietic cells by their lack of CD34, CD45, lets in cells being stained by Oil Red O solution (46, 78) . CD14, and HLA-DR. Stro-1 is specific for clonogenic
In chondrogenesis differentiation, TGF-β2 and TGF-β1 MSCs (73,81,84). These cells can differentiate to form are involved in differentiation (45) . PPAR-γ2, C/EBP, cells with the characteristics of adipose, cartilage, and and retinoic C receptor are involved in adipogenesis bone cells in vitro, and form human bone tissue after (27, 86) . PLZF and CBFA-1 induce osteogenesis (26,49, transplantation into immunodeficient SCID mice (39, 53) . Lastly, Smad3, CBP/p300, and SOX9 induce chon-40). The profile of adhesion molecules is also different drogenesis (33) . Furthermore, lineage repression can from donor to donor and is influenced by the serum used also lead to differentiation. Overexpression of the PPARin the culture (87). Vimentin, laminin, fibronectin, and γ2 gene encoding adipogenic factor also represses Cbfaosteopontin can be synthesized by BMSCs (19) . MSCs 1 gene expression in osteogenic cells (57). also express some markers, such as myofibroblasts (αsmooth muscle actin, smooth muscle myosin heavy Ectoderm Differentiation chain), neurons (nestin, Tuj-1), and endothelial cells (CD146, CD105) transforming growth factor-β (TGF-In neuron differentiation, DMSO, BHA, KCL, forskolin, and hydrocortisone were used for induction (75) . beta) receptor, and various forms of integrin (15, 28, 46, 47, 64, 65, 85) .
In our previous study, we used a three-stage induction protocol (25) with addition of bFGF, β-mercaptoethanol Fibroblast colony forming units (CFU-F) were discovered by Friedenstein et al. They isolated adherent (β-ME), NT-3, NGF, and BDNF. Tuj-1, neurofilament 200, MAP-2, synaptophysin, and γ-aminobutyric acid cells that were colonogenic and able to form colonies from bone marrow stroma and newborn rodents (31).
(GABA) and GFAP were used to assess the capacity of neuronal differentiation (22) . Notch-1 and protein kinase Some mitogenic factors (platelet-derived growth factor, A (PKA) pathway are involved in neuron differentiation stimulating factor (GCSF), granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony- (16, 96, 98) .
stimulating factor (GM-CSF), erythropoietin (EPO), Endoderm Differentiation angiopoietin-2, fibroblast growth factor, placental growth factor (PlGF), platelet-derived growth factor-CC, stem In pancreatic islet β-cell differentiation, nicotinamide and β-ME were used for induction and this resulted in cell factor (SCF), interleukin (IL)-2, IL-3, IL-6, IL-8, and IL-1β are all known to stimulate and mobilize specific morphology, high insulin-1 mRNA content, and synthesis of insulin and nestin (13) . In liver differentia-MSCs (5, 61, 92) . During the process of angiogenesis and vasculogenesis, hematopoietic stem cells (HSC) and en-tion, hepatocyte growth factor and oncostatin M were used for induction and obtained cuboid cells that ex-dothelial progenitor cells (EPC) from bone marrow may show concomitant mobilization due to the physiological pressed appropriate markers (α-fetoprotein, glucose 6phosphatase, tyrosine aminotransferase, and cytokeratin-need of synergistic interactions (48) . In this respect, it is thought that VEGF-A, PlGF, and SDF-1, released by 18) and albumin production in vitro (58) . Recently, murine mesenchymal stem cells can differentiate to en-blood platelets and monocytes, activate metalloproteinase-9 (MMP-9), which mediates a joint mobilization of doderm islet cells with high efficiency. Firstly, MSCs differentiated to endoderm (expressing Sox17, Foxa2, HSCs, EPCs, and MSCs. The interactions between these cells may contribute to the revascularization process (24) . GATA-4, and CK-19), then to pancreatic endoderm (PDX1, Ngn2, NeuroD, PAX4, and Glut-2), and finally HOMING OF MSCs to pancreatic hormone-expressing (insulin, glucagon, and somatostatin) cells (11) . In liver maturation, meso-Recent studies have revealed that stem cells are highly migratory and seem to be attracted to areas of endodermal phenotype was genetically regulated through cytokine signaling, including TGF-β, bone morphogene-brain pathology, such as ischemic regions (1,12). Human MSCs transplanted into fetal sheep will be embed-tic protein, fibroblast growth factor, and other signaling pathways (50) .
ded into various tissues (bone marrow, spleen, thymus, liver) (3). Circulating hematopoietic cells will actively MOBILIZATION OF MSCs cross the endothelial vasculature of different organs and into their bone marrow niches. Homing is also a part of Several growth factors, cytokines, and chemokines have been found to mediate mobilization of MSCs. In host defense and repair (71) . Growth factors, chemokines, and adhesion molecules are signals for the direct both animal and human studies, growth factors VEGF, stromal-derived factor-1 (SDF-1), granulocyte colony-homing effect (17, 54) . MSCs can migrate and home to tissues and organs (2,20,21,29). Chemokine receptors so that they can be used in clinical applications. The factors that influence differentiation are of particular im-and their chemokine ligands are essential components involved in the migration of leukocytes into sites of in-portance to ensure that they are safe for human use. The better the pathways are understood, the greater the possi-flammation (83). CXCL12 [stromal cell-derived factor-1 (SDF-1)] and its receptor CXCR4 are crucial for bone bility that MSCs can be manipulated into the required type of cells. Immune modulation is another important marrow retention, mobilization, and homing of hematopoietic stem cells (59, 72, 92) . MSCs can express a vari-issue in MSC transplantation. As the mechanism is still unclear, it is worth elucidating the roles of molecules in ety of chemokine receptors, which suggests homing affinity may vary depending on the type of tissue (94) .
the immune response that may dictate whether or not an engraftment is successful. Granulocyte colony-stimulating factor causes enhanced stem cell migration towards SDF-1, which is a potential Future Research on MSC Mobilization and Homing advantage in directing and amplifying the homing of endogenous stem cells (9) .
Currently, there are no available data from long-term clinical studies examining drug-mediated mobilization IMMUNE MODULATION OF MSCs and functional modification of endogenous stem cells. In addition to multilineage differentiation, MSCs also
One focus of future research should be the elucidation have powerful immunomodulatory effects, which include of the molecular pathways regulating stem cell levels inhibition of proliferation and function of T cells, B cells, and the function and genetic modification of stem cells and natural killer cells (8, 37, 52, 60) . Underlying the MSCleading to improved functional capacity. The developmediated immunomodulatory mechanisms is a nonspement of pharmacological and genetic strategies for tarcific antiproliferative effect, which is the consequence of geting endothelial progenitor cells will be necessary in cyclin D2 inhibition (80) . Prostaglandin E 2 , nitric oxide, the future (4,24). histocompatibility locus antigen-G, insulin-like growth factor-binding proteins, and tolerogenic antigen-present-CONCLUSION ing cells and indoleamine 2,3-dioxygenase have been re-There are likely numerous sources of human MSCs ported to play a role in this mechanism (80) . Although awaiting discovery. They may be good candidates for the physiologic significance of immunosuppression is unfuture experimental or clinical applications. The mechaclear, the underlying mechanism could involve stromal nisms of differentiation, mobilization, and homing of function. It appears to exert its influence by increasing the MSCs are complex. The multipotency of mesenchymal survival and renewal of parenchymal stem cells. Understem cells makes them an attractive choice for clinical standing these mechanisms and the precise roles of the applications. Future studies should explore the role of molecules involved will be of enormous help in the devel-MSCs in differentiation, transplantation, and immune reopment of future clinical applications, such as transplantasponse in various diseases. tion of stem cells or experimental applications. 
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